Blog

What is it? Hyperosmolar Hyperglycemic Nonketotic Syndrome, or HHNS, is one of two of the most serious metabolic complications of diabetes mellitus (the other is diabetes ketoacidosis, or DKA). This condition is an emergency caused by very high blood sugar (often over 600 mg/dL), and the kidneys try to eliminate the extra blood sugar by putting more sugar in the...

Vidant Medical Center publicizes seven-year outcome data from Monarch Medical Technologies EndoTool at American Diabetes Association 76th Scientific Sessions. Vidant Medical Center, the flagship hospital for Vidant Health in Greenville, NC, is presenting their poster reflecting the improvement in quality of care with patients being treated on EndoTool Glucose Management System. The poster, “Use of a Computer-Guided Glucose Management System...

In our previous blog, we looked at the quick facts behind hyperglycemia and the personalized glucose management software to safely treat hyperglycemia while preventing hypoglycemia. While hyperglycemia often has the spotlight when it comes to blood glucose levels, hypoglycemia is just as alarming. Hypoglycemia is a condition characterized by abnormally low blood glucose levels, usually less than 70 mg/dL. If...

We are familiar with the link between hyperglycemia and increased mortality, even in patients who do not have diabetes. Our past blog posts have emphasized the importance of glucose control as a significant component of a patient’s health, particularly in intensive care environments. To create awareness for prevention, it is imperative to put emphasis on the facts. With regard to...

This past Wednesday, the team at Monarch Medical Technologies announced ground-breaking EREI technology for any hospital scenario where intravenous insulin is administered. Dr. Patrick Burgess, founder and inventor of EndoTool, described the technology as having the potential to nearly eliminate severe hypoglycemia while removing the risk of human oversight. EREI refers to “estimated residual extracellular insulin” present in a patient’s...

This past week was National Nurses Week, and the team at Monarch Medical Technologies would like to take this day to reflect on everything nurses do to enrich our lives. We would like to thank all nurses for the commitments and contributions they make in today’s healthcare and to raise awareness of their role. Additionally, Monarch Medical Technologies would like...

Here are the top 10 reasons to use EndoTool: 10 – Confidence in Outcomes EndoTool is the market leader for safe glucose management for hospitalized patients and is trusted by more than 180 hospitals in the United States. 9 – Simple Process Once a facility begins using EndoTool, nurses follow a simple three-step process for safe dose recommendations. The process...

According to the Centers for Disease Control and Prevention, a surgical site infection is an infection that occurs after surgery in the part of the body where the surgery took place. Surgical site infections can be less serious involving only the skin, or more severe encompassing tissues under the skin, organs, or implanted material. These infections develop in about 1...

This April, Monarch Medical Technologies will participate in the 25th annual Tour de Cure hosted by the American Diabetes Association in Charlotte, North Carolina. The Tour de Cure is a series of fundraising cycling events held in 44 states nationwide to benefit the American Diabetes Association. Monarch Medical Technologies is thrilled to be involved with the community at this year’s Tour...

Glucose Management Software This blog series has been used to educate our readers on inpatient glucose management. In part 1, we explored the risks and complications, and in part 2, we explored best practices recommended by the American Diabetes Association and The Joint Commission. In this post, we will come full circle with the benefits of inpatient glucose management software....

ADA and Joint Commission Guidelines for Best Practices In part 1 of this series, we explained the risks and complications associated with inpatient glucose control. We learned that occurrences include hyperglycemia, hypoglycemia, poor treatment and/or lack of control, and hospital-acquired conditions. The American Diabetes Association (ADA) and The Joint Commission have created recommendations for diabetes care in the hospital. Some...

Risks and Complications Risks and complications associated with inpatient glucose control spark some of the most dreaded conversations exchanged in healthcare. Clinicians are accustomed with these situations and would prefer little or no occurrence.  The detrimental obstacles include: Hyperglycemia – High blood sugar in hospitalized patients is common and associated with increased risk of infection, mortality and escalated cost. Hypoglycemia...

What is DKA? Diabetic ketoacidosis, or DKA, is a serious complication of diabetes that occurs when your body produces high levels of blood acids called ketones. How does DKA occur? When the body cannot produce enough insulin, the body begins to burn fat for energy and produces a buildup of acids in the bloodstream called ketones. Once the ketones build up...

Every day, the United States fights the ongoing battle regarding the cost of healthcare. Reimbursement rates are dropping and hospitals question every expense in order to find justification for new tools and treatment options. The complex issue occurs when addressing all conditions, including hyperglycemia, a significant concern that is linked to higher mortality rates. Despite the understanding that manifestations of...

Estimated residual extracellular insulin, or EREI, refers to residual insulin present in a patient’s body. Every patient receiving insulin therapy requires personalized treatment based on their individual makeup. In addition to this, each patient’s need for insulin is not only different, but, ever-changing based on activity level, meals consumed and stress. The amount of residual insulin present in a person’s...